ArticleJournal of translational medicine2021

Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma.

Lan Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.